Genome Therapeutics to Use Genomica s Software for Pharmacogenomics | GenomeWeb

NEW YORK, Sept 27 – As genomics software company Genomica of Boulder Colo., gears up for an expected $85 million IPO this week, it said Wednesday that it had licensed its Discovery Manager software to Genome Therapeutics (Nasdaq: GENE).  

Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.